home news forum careers events suppliers solutions markets expos directories catalogs resources advertise contacts
News Page

The news
beyond the news
Index of news sources
All Africa Asia/Pacific Europe Latin America Middle East North America
News archive 1997-2008

Arcadia Biosciences announces leadership transition - CEO Stan Jacot replaced by CFO Thomas J. Schaefer

Dallas, Texas, USA
July 9, 2024

Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced that CEO Stan Jacot has left the company and been replaced by Thomas J. Schaefer, effective July 5, 2024.  Schaefer was previously Arcadia’s chief financial officer and will be replaced in that role by Mark Kawakami, Arcadia’s current vice president of finance.

“On behalf of Arcadia, I would like to thank Stan for his many contributions to the company,” said Board of Directors Chairman Kevin Comcowich. “Under his leadership, Arcadia expanded the GoodWheat brand into three categories, sold the brand to Above Food, monetized a portion of our wheat IP, revamped Zola coconut water and divested or exited several unprofitable businesses. We wish him all the best in the next phase of his career.”

Schaefer is an accomplished executive with more than 20 years of experience in investments and corporate finance. He began his career as an equity research analyst and later joined a Fortune 500 company where he helped lead several acquisitions and divestitures. In 2013, Schaefer moved into consumer products where he led teams, developed long-range strategies and helped launch new products across a variety of industries including vitamins and apparel. He later served as director of finance at Flavor Producers, a portfolio company owned by private equity firm GTCR that specialized in beverages and snacks, before joining Arcadia in 2020.

Schaefer earned a bachelor of business administration in economics and finance from McKendree University and a master of business administration (MBA) from the Marshall School of Business at the University of Southern California. He also holds the Chartered Financial Analyst (CFA) designation.

“T.J. has played a significant role in the company’s transition from ag research to consumer goods, and he was instrumental in the development of Project Greenfield, the company’s strategic plan to unlock the company’s potential and provide a path to profitability,” said Comcowich. “We welcome his leadership as we continue to expand the footprint of Zola coconut water, explore strategic opportunities, monetize our IP and create value for our shareholders.”

Schaefer’s successor as chief financial officer, Mark Kawakami, joined Arcadia in 2021, and he has held several key positions, most recently as the vice president of finance. Kawakami brings more than 20 years of finance and accounting experience to the role, with a background in industries such as convenience and retail grocery, food manufacturing, consumer packaged goods and financial services. He is a graduate of the University of Southern California where he earned both a bachelor’s degree and MBA.


More news from: Arcadia Biosciences

Website: http://www.arcadiabio.com

Published: July 10, 2024

The news item on this page is copyright by the organization where it originated
Fair use notice


  Archive of the news section


Copyright @ 1992-2024 SeedQuest - All rights reserved